DK1796717T3 - Kombinationsvaccine - Google Patents
KombinationsvaccineInfo
- Publication number
- DK1796717T3 DK1796717T3 DK05803574.2T DK05803574T DK1796717T3 DK 1796717 T3 DK1796717 T3 DK 1796717T3 DK 05803574 T DK05803574 T DK 05803574T DK 1796717 T3 DK1796717 T3 DK 1796717T3
- Authority
- DK
- Denmark
- Prior art keywords
- antigen
- combination vaccine
- relates
- combination
- confer
- Prior art date
Links
- 229940001442 combination vaccine Drugs 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 4
- 102000036639 antigens Human genes 0.000 abstract 4
- 108091007433 antigens Proteins 0.000 abstract 4
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000193449 Clostridium tetani Species 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04024103A EP1645283A1 (en) | 2004-10-08 | 2004-10-08 | Combination vaccine |
| PCT/EP2005/010845 WO2006037658A1 (en) | 2004-10-08 | 2005-10-07 | Combination vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1796717T3 true DK1796717T3 (da) | 2012-05-29 |
Family
ID=34926925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05803574.2T DK1796717T3 (da) | 2004-10-08 | 2005-10-07 | Kombinationsvaccine |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20090130146A1 (da) |
| EP (2) | EP1645283A1 (da) |
| JP (1) | JP2008515842A (da) |
| AT (1) | ATE547116T1 (da) |
| CA (1) | CA2583221A1 (da) |
| DK (1) | DK1796717T3 (da) |
| PL (1) | PL1796717T3 (da) |
| WO (1) | WO2006037658A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2144998T1 (sl) * | 2007-04-06 | 2017-05-31 | Takeda Vaccines, Inc. | Postopki in sestavki za žive atenuirane viruse |
| GB0905570D0 (en) * | 2009-03-31 | 2009-05-13 | Novartis Ag | Combined vaccines |
| CN102348466B (zh) | 2008-08-29 | 2014-05-07 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 西尼罗病毒疫苗 |
| GB0822633D0 (en) * | 2008-12-11 | 2009-01-21 | Novartis Ag | Formulation |
| BR112012014689B1 (pt) * | 2009-12-16 | 2019-11-12 | Serum Institute Of India Private Limited | composição imunogênica |
| CN103501811B (zh) * | 2011-01-13 | 2016-03-30 | 变异生物技术公司 | 用于治疗病毒感染的组合物和方法 |
| BR122019023542B1 (pt) | 2011-03-14 | 2022-02-15 | Boehringer Ingelheim Vetmedica, Inc | Composição imunogênica compreendendo uma ou mais cepas de vírus da rinite equina b (erbv) inativado e seu método de preparação |
| KR101839496B1 (ko) * | 2011-06-01 | 2018-03-19 | 시아먼 유니버시티 | 디프테리아 독소 무독성 돌연변이 씨알엠197 또는 그의 단편을 포함하는 융합 단백질 |
| GB2495341B (en) | 2011-11-11 | 2013-09-18 | Novartis Ag | Fermentation methods and their products |
| AU2013208693B2 (en) | 2012-01-12 | 2017-12-07 | Variation Biotechnologies Inc. | Compositions and methods for treating viral infections |
| CN104244984B (zh) | 2012-01-27 | 2020-03-31 | 变异生物技术公司 | 用于治疗剂的方法和组合物 |
| US9546361B2 (en) * | 2012-10-12 | 2017-01-17 | Lehigh University | Thermally stable enzymes, compositions thereof and methods of using same |
| KR20240145520A (ko) * | 2022-03-18 | 2024-10-07 | 덴카 주식회사 | 링커에 의해 연결된 캡시드 단백질을 포함하는 바이러스 유사입자 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT405940B (de) * | 1996-06-21 | 1999-12-27 | Immuno Ag | Verfahren zur gewinnung und reinigung von rekombinantem, nicht-lipidiertem osp-protein |
-
2004
- 2004-10-08 EP EP04024103A patent/EP1645283A1/en not_active Withdrawn
-
2005
- 2005-10-07 PL PL05803574T patent/PL1796717T3/pl unknown
- 2005-10-07 CA CA002583221A patent/CA2583221A1/en not_active Abandoned
- 2005-10-07 EP EP05803574A patent/EP1796717B1/en not_active Expired - Lifetime
- 2005-10-07 WO PCT/EP2005/010845 patent/WO2006037658A1/en not_active Ceased
- 2005-10-07 US US11/664,775 patent/US20090130146A1/en not_active Abandoned
- 2005-10-07 DK DK05803574.2T patent/DK1796717T3/da active
- 2005-10-07 JP JP2007535108A patent/JP2008515842A/ja active Pending
- 2005-10-07 AT AT05803574T patent/ATE547116T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| ATE547116T1 (de) | 2012-03-15 |
| US20090130146A1 (en) | 2009-05-21 |
| CA2583221A1 (en) | 2006-04-13 |
| EP1796717A1 (en) | 2007-06-20 |
| EP1645283A1 (en) | 2006-04-12 |
| PL1796717T3 (pl) | 2012-08-31 |
| JP2008515842A (ja) | 2008-05-15 |
| WO2006037658A1 (en) | 2006-04-13 |
| EP1796717B1 (en) | 2012-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2097102T3 (pl) | Szczepionka skojarzona o zmniejszonej ilości antygenu wirusa polio | |
| DK1796717T3 (da) | Kombinationsvaccine | |
| DK1951296T4 (da) | Celleafledte viral vacciner med lave niveauer af restcelle-DNA | |
| PH12011502633A1 (en) | Vaccines and methods to treat canine influenza | |
| MX341842B (es) | Virus de la influenza capaces de infectar canidos y usos de los mismos. | |
| NZ577405A (en) | Vaccines including antigen from four strains of influenza virus | |
| DE60226911D1 (de) | Entwicklung einer Vakzine zur Prävention von Infektionen mit Filovirus bei Primaten | |
| TW200806316A (en) | Yeast-based vaccine for inducing an immune response | |
| SG156652A1 (en) | Yeast-based therapeutic for chronic hepatitis c infection | |
| ATE554789T1 (de) | Neues hundeinfluenza-virus und imfpstoff hierfür | |
| WO2007002470A3 (en) | Inactivated chimeric vaccines and related methods of use | |
| AU2017261706A1 (en) | Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process | |
| TW200617166A (en) | Multivalent avian influenza vaccines | |
| ATE508185T1 (de) | Virosomenpartikel mit antigenen aus influenzavirus und hepatitis-b-virus | |
| RU2013135887A (ru) | Композиции для комплекса респираторных заболеваний собак | |
| MX2007002659A (es) | Composicion vacunal contra el virus de la hepatitis c. | |
| DE60238554D1 (de) | Vakzine gegen infektionskrankheiten | |
| UA4626U (uk) | Бівалентна інактивована концентрат-вакцина проти інфекційного ринотрахеїту та вірусної діареї великої рогатої худоби | |
| DE602006018985D1 (de) | Zusammensetzung mit einem kolloidalen synthetischen bioresorbierbaren vektor und einem viralen vektor | |
| TH81792A (th) | วัคซีน | |
| TH99635B (th) | การป้องกันและการรักษา pcvd ที่ไม่แสดงอาการ |